A Study to Assess the Effect of Capivasertib on Midazolam in Patients With Advanced Solid Tumours

Trial Identifier: D3614C00003
Sponsor: AstraZeneca
NCTID:: NCT04958226
Start Date: October 2021
Primary Completion Date: February 2023
Study Completion Date: February 2023
Condition: Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
Spanish (US) Translation

Trial Locations

Country Location
US, CA West Hollywood, CA, US, 90048
US, CO Aurora, CO, US, 80045
US, MD Baltimore, MD, US, 21201
US, MS Jackson, MS, US, 39213
US, NC Durham, NC, US, 27710
US, OH Cincinnati, OH, US, 45219
US, OH Cleveland, OH, US, 44106
US, PA Pittsburgh, PA, US, 15232
US, TX Dallas, TX, US, 75251
US, VA Fairfax, VA, US, 22031